Renal Cancer - Results from #3060

Creating patient-specific anatomical models for 3D printing and AR/VR: a supplement for the 2018 Radiological Society of North America (RSNA) hands-on course. January 9, 2020

Safety and Efficacy of Direct Oral Anticoagulant Therapy in Patients With Cancer. January 9, 2020

Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma. January 9, 2020

On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective Study. January 8, 2020

PAK1 expression determines poor prognosis and immune evasion in metastatic renal cell carcinoma patients. January 8, 2020

Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma. January 8, 2020

Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update. January 7, 2020

Low Expression of Single-stranded DNA Binding Protein 2 (SSBP2) Predicts Unfavourable Postoperative Outcomes in Patients With Clear Cell Renal Cell Carcinoma. January 7, 2020

Metastasis of renal cell carcinoma to the vocal cord ten years after radical nephrectomy: A case report. January 7, 2020

Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101. January 7, 2020

A Review of Papillary Renal Cell Carcinoma and MET Inhibitors. January 7, 2020

Does Bone-targeted Therapy Benefit Patients with Metastatic Renal Cell Carcinoma? January 7, 2020

The Roles of Cullin-2 E3 Ubiquitin Ligase Complex in Cancer. January 6, 2020

Survival benefit of nephron-sparing surgery for patients with pT1b renal cell carcinoma: A population-based study. January 6, 2020

Evaluation of immunotherapy and targeted therapy treatment on renal cell carcinoma: A Bayesian network analysis. January 6, 2020

Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma. January 3, 2020

Tumor response criteria for assessing pazopanib first-line therapy in patients with metastatic renal cell carcinoma (mRCC). January 3, 2020

Prognostic value of infiltrating immune cells in clear cell renal cell carcinoma (ccRCC). January 3, 2020

Three novel hub genes and their clinical significance in clear cell renal cell carcinoma. January 2, 2020

The covalent CDK7 inhibitor THZ1 enhances temsirolimus-induced cytotoxicity via autophagy suppression in human renal cell carcinoma. January 2, 2020

Page 154 of 456